- EmployersMay expand access to group-style coverage for individuals, sole proprietors, and small employers by enabling formation…
- ConsumersCould increase consumer choice and product variety (including lower-cost, drug-only plans) and foster competition among…
- EmployersMay reduce administrative burden on small employers by providing pooled purchasing, standardized enrollment/accounting…
Health Marketplace for All Act of 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
This bill amends the Employee Retirement Income Security Act (ERISA) to create a new category called a "health marketplace pool" and to deem such pools to be "employers" for the limited purpose of offering group health plans or group health insurance coverage. The statute sets organizational requirements for these pools (including that membership may not be conditioned on health-status factors), authorizes them to offer group plans or contract with issuers, permits administrative services, allows multiple pools per geographic area, and explicitly allows plans that cover drugs (including over-the-counter drugs) as the sole benefit.
Progressives emphasize risk to consumers and state protections; conservatives emphasize expanded choice and market competition.
Relative to its intended legislative type, this bill clearly identifies and integrates a new statutory category into ERISA and supplies many definitional and substantive provisions governing what a 'health marketplace pool' may do, but it omits important implementation, fiscal, oversight, and consumer-protection details that would typically be expected for a substantive change of this scope.
This bill amends the Employee Retirement Income Security Act (ERISA) to create a new category called a "health marketplace pool" and to deem such pools to be "employers" for the limited purpose of offering group health plans or group health insurance coverage.
The statute sets organizational requirements for these pools (including that membership may not be conditioned on health-status factors), authorizes them to offer group plans or contract with issuers, permits administrative services, allows multiple pools per geographic area, and explicitly allows plans that cover drugs (including over-the-counter drugs) as the sole benefit.
The bill also clarifies that participation in or facilitation of a pool does not create an employer or joint-employer relationship for other purposes and makes conforming amendments to ERISA definitions and fiduciary language.
Content alone suggests modest prospects: the bill is a focused statutory change (not a budgetary spending bill) but touches a sensitive area—health insurance market structure and ERISA preemption—that typically provokes entrenched stakeholder and ideological responses. The lack of built‑in compromise features, absence of explicit funding or pilot phases, and potential for legal and state‑regulatory friction lower its odds of becoming law absent major amendment, substantial bipartisan negotiation, or strong political priority.
Relative to its intended legislative type, this bill clearly identifies and integrates a new statutory category into ERISA and supplies many definitional and substantive provisions governing what a 'health marketplace pool' may do, but it omits important implementation, fiscal, oversight, and consumer-protection details that would typically be expected for a substantive change of this scope.
Progressives emphasize risk to consumers and state protections; conservatives emphasize expanded choice and market competition.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesBy deeming pools "employers" under ERISA, the bill could trigger federal preemption of state insurance regulation for p…
- Potential burdenAllowing varied rate-setting and drug-only plans may enable regulatory or market segmentation that produces adverse sel…
- Permitting processPermitting plans that cover only drugs (including OTC drugs) risks producing narrow coverage that leaves enrollees unin…
Why the argument around this bill splits.
Progressives emphasize risk to consumers and state protections; conservatives emphasize expanded choice and market competition.
A mainstream liberal/left-leaning person would likely view this bill with skepticism.
While it could expand options for some people, they would be concerned that creating ERISA-classified "pools" could be used to circumvent state consumer protections and benefit mandates, and that permitting drug-only plans risks fragmenting coverage and weakening comprehensive care.
They would note the bill allows variation in rates and contains limited detail on solvency, consumer protections, and how these pools will interact with existing ACA marketplaces.
A centrist/moderate observer would see potential positives and negatives.
They might appreciate the market-expanding intent (more pooled purchasing, administrative efficiency) and the plain-language protections against health-status gating for membership, but would be cautious about unintended consequences such as regulatory gaps, impacts on existing insurance markets, and the overall fiscal and consumer-protection tradeoffs.
They would look for empirical evidence that such pools lower premiums without degrading benefits or destabilizing ACA/commercial markets.
A mainstream conservative commentator would generally view the bill favorably as a pro-competition, market-oriented reform that broadens options for purchasing group coverage and reduces regulatory barriers.
They would emphasize that deeming a marketplace pool an "employer" under ERISA allows associations and small entities to band together, potentially lowering costs and increasing flexibility, and they would welcome the explicit allowance of varied plan designs, including drug-only coverage.
Some conservatives might still ask for clarifications about limiting new federal mandates or unintended federal overreach, but overall the bill aligns with a preference for private-market solutions over additional federal regulation.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content alone suggests modest prospects: the bill is a focused statutory change (not a budgetary spending bill) but touches a sensitive area—health insurance market structure and ERISA preemption—that typically provokes entrenched stakeholder and ideological responses. The lack of built‑in compromise features, absence of explicit funding or pilot phases, and potential for legal and state‑regulatory friction lower its odds of becoming law absent major amendment, substantial bipartisan negotiation, or strong political priority.
- No Congressional Budget Office estimate or cost/fiscal analysis is included in the text; the magnitude and distribution of economic effects (premiums, insurer behavior, state regulatory revenue) are unknown.
- The bill’s real‑world impact depends on how implementing agencies and courts interpret ERISA preemption over state insurance laws in light of the new 'deemed employer' category.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize risk to consumers and state protections; conservatives emphasize expanded choice and market competition.
Content alone suggests modest prospects: the bill is a focused statutory change (not a budgetary spending bill) but touches a sensitive are…
Relative to its intended legislative type, this bill clearly identifies and integrates a new statutory category into ERISA and supplies many definitional and substantive provisions governing what a 'health marketplace p…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.